Considering the binding relationship between SNAI2 and SLC7A11 promoter as aforementioned, it is suggested that SNAI2 knockdown may promote ferroptosis and suppress ovarian cancer progression by directly targeting to and downregulating SLC7A11. Here, SLC7A11 is linked to ovarian carcinoma.